Michael Contreras MD in Denver, Colorado

Home Colorado Denver

Michael Contreras MD has Dermatology as his primary medical specialty. Their primary office is: 425 S Cherry St in Denver, Colorado.

They're a part of the: Core Dermatology Pllc medical group which has around 4 members. You can call their office at 303-355-3000 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of New Mexico School Of Medicine and graduated in 2001 (around 24 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Michael E Contreras MD Office Phone and Directions

Michael Contreras MD
Core Dermatology Pllc
425 S Cherry St
Denver, Colorado 80246
303-355-3000

Patient Ratings
Please rate your experience with Michael Contreras MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 303-355-3000

Enter a starting address:

Healthcare Info for Michael Contreras MD

Medical School: University Of New Mexico School Of Medicine
Graduation Year: 2001
The Primary Medical Specialty for Michael Contreras MD is listed as: Dermatology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 24
PAC (PECOS ID)#: 4880625664
NPI #: 1457367013
NPI Created On: 08/01/2006
NPI Last Updated Listed as: 03/17/2018
Primary Taxonomy Code: 207N00000X
License Number:
48593
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.

Services and Procedures include:

Tangential biopsy of single skin lesion
Tangential biopsy of additional skin lesion
Punch biopsy of single skin lesion
Removal of malignant growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs
Removal of malignant growth (1.1 to 2.0 centimeters) of the face, ears, eyelids, nose, or lips
Destruction of skin growth
Destruction of 2-14 skin growths
Destruction of up to 14 skin growths
Destruction of malignant growth (0.6 to 1.0 centimeters) of trunk, arms, or legs
Biopsy of ear
Application of light and light-sensitive drugs to aid destruction of premalignant skin growths, per session
New patient office or other outpatient visit, typically 30 minutes
Established patient office or other outpatient visit, typically 10 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788258341

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Immunology

Name of Drug #1: REMICADE

Open Associated Drug #1: 57894-030-01

Drug or Biological: Biological

Product Category #2: Immunology

Name Of Drug #2:: STELARA

Associated Drug #2: 57894-060-03

Drug or Biological #3:: Biological

Product Category #3: Immunology

Name of Drug: SIMPONI ARIA

Name Of Drug #3: 57894-350-01

Drug or Biological: Biological

Product Category #4: Immunology

Name of Drug #4: SIMPONI

Associated Drug #4: 57894-070-01

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794282651

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: SKYRIZI

Open Associated Drug #1: 0074-2042-02

Drug or Biological: Biological

Product Category #2: IMMUNOLOGY

Name Of Drug #2:: HUMIRA

Associated Drug #2: 0074-0554-02

Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794282659

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: SKYRIZI

Open Associated Drug #1: 0074-2042-02

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794282653

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: SKYRIZI

Open Associated Drug #1: 0074-2042-02

Drug or Biological: Biological

Product Category #2: IMMUNOLOGY

Name Of Drug #2:: HUMIRA

Associated Drug #2: 0074-0554-02

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794282655

Being Disputed:: No

Product Related: No

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794282657

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: SKYRIZI

Open Associated Drug #1: 0074-2042-02

Payments Total: $2

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794282661

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: SKYRIZI

Open Associated Drug #1: 0074-2042-02

Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794282663

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: SKYRIZI

Open Associated Drug #1: 0074-2042-02

Payments Total: $2

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794282665

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: SKYRIZI

Open Associated Drug #1: 0074-2042-02

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794282667

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: SKYRIZI

Open Associated Drug #1: 0074-2042-02

Dermatology Professionals in Denver

1.
Margaret Muldrow

1601 E 19th Ave
Denver, CO
Hm Medical Consultants, Professional Llc

2.
Whitney High MD

777 Bannock St
Denver, CO
Denver Health And Hospital Authority

3.
Whitney High MD

500 Quivas St
Denver, CO
Denver Health And Hospital Authority

4.
Peggy Liao MD

2130 Stout St
Denver, CO
Colorado Coalition For The Homeless

5.
Peggy Liao MD

2200 E 18th Ave
Denver, CO
Advanced Dermatology Of Colorado Pc

6.
James Swinehart MD

950 E Harvard Ave
Denver, CO

Providers in Core Dermatology Pllc

1.Michael Contreras Md

425 S Cherry St
Denver Co 80246-1242
Core Dermatology Pllc
Dermatology

2.Stephanie Frankel

425 S Cherry St
Denver Co 80246-1242
Core Dermatology Pllc
Dermatology

3.Nicole Neuschler

425 S Cherry St
Denver Co 80246-1242
Core Dermatology Pllc
Dermatology

4.Jessica Olander

425 S Cherry St
Denver Co 80246-1242
Core Dermatology Pllc
Dermatology

View all 4 members of Core Dermatology Pllc medical group